Article

Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic Individuals

2022-05-02

Abstract excerpt

<h4>ABSTRACT</h4> <h4>IMPORTANCE</h4> Since December, 2020, the ID NOW was implemented for use in 4 different populations across Alberta: in mobile units as part of community outbreak response, COVID-19 community collection sites, emergency shelters and addiction treatment facilities (ES), and hospitals. <h4>OBJECTIVE</h4> Diagnostic evaluation of the ID NOW in various real world settings among symptomatic and asy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b57b5dc0-1db5-5a36-b886-e4450eb1e793
DOI: 10.1101/2022.04.30.22274189

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic IndividualsDOI 10.1101/2022.04.30.22274189Read

Evaluation of the ID NOW Among Symptomatic Individuals During the Omicron WaveSemantic proximity Read

Relative Sensitivity of ID NOW and RT-PCR for Detection of SARS-CoV-2 in an Ambulatory Population: Clinical Evaluation, Systematic Review and Meta-analysisSemantic proximity Read

Acceptable Performance of the Abbott ID NOW Among Symptomatic Individuals with Confirmed COVID-19Semantic proximity Read

Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparisonSemantic proximity Read

Finding a Needle in a Haystack: Design and Implementation of a Digital Site-less Clinical Study of Serial Rapid Antigen Testing to Identify Asymptomatic SARS-CoV-2 InfectionSemantic proximity Read

Use cases for COVID-19 screening and surveillance with rapid antigen-detecting tests: a systematic reviewSemantic proximity Read

Home Testing for Sars-Cov-2 and Impact on Surveillance in New York StateSemantic proximity Read

Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 antigen test in general practice – a prospective multicenter validation and implementation studySemantic proximity Read

INSIGHT: a population scale COVID-19 testing strategy combining point-of-care diagnosis with centralised high-throughput sequencingSemantic proximity Read

Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patientsSemantic proximity Read

Accuracy of COVID-19 self-tests with unsupervised nasal or nasal plus oropharyngeal self-sampling in symptomatic individuals in the Omicron periodSemantic proximity Read

Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative PatientsSemantic proximity Read